NCT06208618

Brief Summary

The deterioration of glycemic control in adolescents with Type 1 diabetes (T1DM) is a genuine cause for concern. Possible reasons for worsening glycemic control in youth include lack of monitoring, inadequate self-care, psychosocial factors, lack of family support and parental supervision, non-adherence to treatment, pubertal increases in insulin resistance, and insufficient transition from pediatric to adult care. In adolescents with established T1DM who transition to adult-focused care, there is observed disengagement or complete detachment from care. Improving glycemic control during adolescence is a critical stage to enhance and reduce complications associated with T1DM. Adolescents with T1DM require appropriate daily insulin therapy, regular blood sugar monitoring, physical activity, healthy nutrition, education, and support to delay or prevent diabetes-related complications.This study aims to determine the impact of education and motivational interviews conducted through tele-nursing on the management of diabetes in adolescents with Type 1 diabetes.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
96

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2024

Completed
9 days until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 17, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2024

Completed
Last Updated

February 13, 2024

Status Verified

February 1, 2024

Enrollment Period

5 months

First QC Date

January 6, 2024

Last Update Submit

February 10, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • HbA1c level

    HbA1c level

    At the beginning of the study, at the 3rd month, and at the 6th month

  • Diabetes management self-efficacy

    It will be measured using the "Diabetes Management Self-Efficacy Scale in Adolescents with Type 1 Diabetes". The scale consists of a total of 26 items under four sub-dimensions named "medical treatment and nutrition", "glycemic assessment", "talking about your diabetes" and "honesty towards yourself and others".The items in the scale are answered according to the 5-point Likert system as "Definitely yes (1) - Definitely no (5)". Self-efficacy scores are summed and divided by the total number of items to indicate the strength of perceived self-efficacy for different levels of performance on the total of diabetes self-management activities. High scores on the scale represent low self-efficacy. The Cronbach Alpha reliability coefficient of the overall scale is 0.85; for the sub-dimensions are 0.80, 0.75, 0.70 and 0.70, respectively.

    At the beginning of the study, at the 3rd month, and at the 6th month

Secondary Outcomes (1)

  • Belief in a healthy lifestyle

    At the beginning of the study, at the 3rd month, and at the 6th month

Study Arms (2)

Motivational interviews

EXPERIMENTAL

At the beginning of the study, individual face-to-face diabetes education will be provided for each adolescent in the study group on days corresponding to their routine medical appointments in the diabetes education room. The diabetes education will include the following topics: * What is Diabetes? * Treatment in Diabetes * Insulin Therapy * Nutritional Therapy * Physical Activity/Exercise * Acute Complications of Diabetes * Hypoglycemia * Hyperglycemia * Diabetic Ketoacidosis * Diabetes Management in IIlness The adolescents in the study group will undergo a total of 6 motivational interviews, conducted once a month. Three of these interviews will be face-to-face (at the beginning of the study, at the 3rd month, and at the 6th month), while the remaining three will be conducted remotely using the WhatsApp video call feature (in the 2nd, 4th, and 5th months).

Other: Education and Motivational Interviews

Routine follow-up

NO INTERVENTION

The routine follow-up conducted by the diabetes education unit will continue for the study group, and no interventions will be made as part of the research. The study group will undergo a pre-test at the beginning of the study, a follow-up test at the 3rd month, and a post-test at the 6th month as part of the research.

Interventions

The diabetes education aimed at supporting diabetes self-management in adolescents will include the following topics: * What is Diabetes? * Treatment in Diabetes * Insulin Therapy * Nutritional Therapy * Physical Activity/Exercise * Acute Complications of Diabetes * Hypoglycemia * Hyperglycemia * Diabetic Ketoacidosis * Diabetes Management in Illness Motivational interviews will consist of the following stages: * First Meeting - Pre-awareness (Pre-contemplation) * Second Meeting - Awareness (Contemplation) * Third Meeting - Preparation * Fourth Meeting - Taking Action (Action) * Fifth Meeting - Maintenance * Sixth Meeting - Termination or Review

Motivational interviews

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Diagnosed with Type 1 diabetes at least 6 months ago
  • Under follow-up at Kütahya Evliya Çelebi Health Sciences University Training and Research Hospital Diabetes Education Unit
  • Having an HbA1c level above 7.5% in the most recent measurement
  • Having a smartphone

You may not qualify if:

  • Refusal of legal guardian or the adolescent themselves to participate in the research
  • Difficulty in communication or answering questions
  • Having hearing, speech, vision, or cognitive impairments
  • Being in the honeymoon period of Type 1 diabetes
  • Having a second autoimmune disease, such as celiac disease, besides Type 1 diabetes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Eskisehir Osmangazi University

Eskişehir, Odunpazarı, 26040, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Interventions

Educational Status

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Socioeconomic FactorsPopulation Characteristics

Study Officials

  • Pınar Duru, Ph.D.

    Eskisehir Osmangazi University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Single-blind
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: A single-center, single-blind, parallel-group, randomized controlled design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

January 6, 2024

First Posted

January 17, 2024

Study Start

January 15, 2024

Primary Completion

June 15, 2024

Study Completion

June 15, 2024

Last Updated

February 13, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations